Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $283.30 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $86.11 | 5 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $53.14 | 6 | $0 (2021) |
| Eisai Inc. | $29.48 | 2 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.69 | 2 | $0 (2022) |
| Lundbeck LLC | $17.11 | 1 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $16.05 | 1 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $15.46 | 1 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $14.54 | 1 | $0 (2023) |
| Axsome Therapeutics, Inc. | $14.45 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $11.27 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.11 | 1 | Lundbeck LLC ($17.11) |
| 2023 | $44.45 | 3 | Supernus Pharmaceuticals, Inc. ($15.46) |
| 2022 | $83.60 | 5 | Teva Pharmaceuticals USA, Inc. ($53.97) |
| 2021 | $138.14 | 12 | Sunovion Pharmaceuticals Inc. ($53.14) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.11 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Neurology | ||||||
| 05/26/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $15.46 | General |
| Category: PSYCHOLOGY | ||||||
| 09/29/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Central Nervous System | ||||||
| 07/21/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Central Nervous System | ||||||
| 04/22/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Central Nervous System | ||||||
| 04/01/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Neuropsychiatry | ||||||
| 10/28/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: CNS | ||||||
| 08/11/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Central Nervous System | ||||||
| 08/05/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $14.26 | General |
| Category: Neurology | ||||||
| 06/16/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Central Nervous System | ||||||
| 06/15/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $3.88 | General |
| Category: CNS | ||||||
| 05/18/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: CNS | ||||||
| 04/19/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: CNS | ||||||
| 03/11/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $10.12 | General |
| Category: CNS | ||||||
| 03/09/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: Neuroscience | ||||||
| 02/11/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: CNS | ||||||
| 02/09/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: NEUROSCIENCE | ||||||
| 01/21/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $15.22 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 133 | 416 | $66,325 | $22,431 |
| 2022 | 3 | 139 | 410 | $67,520 | $25,219 |
| 2021 | 3 | 186 | 477 | $81,770 | $30,313 |
| 2020 | 3 | 92 | 111 | $23,710 | $8,844 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 340 | $50,610 | $16,443 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 64 | $10,975 | $4,613 | 42.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 12 | 12 | $4,740 | $1,375 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 310 | $46,500 | $16,721 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 84 | $14,700 | $6,438 | 43.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 16 | 16 | $6,320 | $2,060 | 32.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 100 | 342 | $51,200 | $17,930 | 35.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 89 | $15,550 | $6,869 | 44.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 46 | 46 | $15,020 | $5,514 | 36.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 54 | 54 | $16,260 | $5,679 | 34.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 44 | $5,500 | $2,237 | 40.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 13 | $1,950 | $929.03 | 47.6% |
About Anthony Kramer
Anthony Kramer is a Psychiatric/Mental Health healthcare provider based in Bemidji, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2015. The National Provider Identifier (NPI) number assigned to this provider is 1972997831.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anthony Kramer has received a total of $283.30 in payments from pharmaceutical and medical device companies, with $17.11 received in 2024. These payments were reported across 21 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($283.30).
As a Medicare-enrolled provider, Kramer has provided services to 550 Medicare beneficiaries, totaling 1,414 services with total Medicare billing of $86,807. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Bemidji, MN
- Active Since 03/27/2015
- Last Updated 07/07/2020
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1972997831
Products in Payments
- AUSTEDO (Drug) $86.11
- LATUDA (Drug) $53.14
- Dayvigo (Drug) $29.48
- REXULTI (Drug) $17.11
- INGREZZA (Drug) $16.05
- QELBREE (Drug) $15.46
- ABILIFY MAINTENA (Drug) $14.54
- Sunosi (Drug) $14.45
- TRINTELLIX (Drug) $13.58
- VYVANSE (Drug) $12.11
- INVEGA SUSTENNA (Drug) $11.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Bemidji
Ms. Cynthia Schackman, Arnp Or Pfmhnp, ARNP OR PFMHNP
Psychiatric/Mental Health — Payments: $332.72
Julie Beevor, Cnp, Pmhnp-Bc, CNP, PMHNP-BC
Psychiatric/Mental Health — Payments: $224.13
Ms. Andrea Craig, Aprn, Cnp, APRN, CNP
Psychiatric/Mental Health — Payments: $211.77
Melissa Fairchild, Cnp, CNP
Psychiatric/Mental Health — Payments: $45.36
Stephanie Harnack, Aprn, Cnp, APRN, CNP
Psychiatric/Mental Health — Payments: $38.42
Mrs. Gina Ballard-Schmunk, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $28.99